Dr. James E. Haddix, DMD ,
-
Non-Surgical Alternatives to Plastic Surgery: Do They Really Work?
Non-surgical aesthetic treatments—such as neuromodulators, dermal fillers, laser and light therapies, radiofrequency or ultrasound skin tightening, chemical peels, and body-contouring options like cryolipolysis—can meaningfully improve mild to moderate concerns with less downtime and lower upfront risk than surgery. They work best for fine lines, early laxity, uneven tone/texture, and small pockets of fat, but they cannot replicate the dramatic or long-lasting changes of surgical procedures and often require maintenance sessions. Safety and results depend heavily on proper patient selection, realistic expectations, and a qualified provider using evidence-based, FDA-cleared devices and products. For patients and caregivers, the key value lies in customizable, stepwise plans that fit personal goals, budget, and recovery needs, with clear discussion of benefits, limits, side effects, and total long-term cost. Ultimately, “worth it” is individual—seek a consultation that includes photos, expected longevity of results, and a timeline comparing non-surgical care to surgical options.
-
Aurora Sheboygan Prices – KEPPRA is $195
At Aurora Medical Center Sheboygan, we prioritize providing our patients with comprehensive financial information upfront. For Charge Code 10002558, regarding KEPPRA, which is classified under revenue code 301 and associated with CPT code 80177, the designated fee stands at $195. Our aim through the CompareMedCosts program is to furnish you with all the details you need to make informed healthcare decisions, offering clarity and transparency around the costs associated with your care.
-
Aurora Sheboygan Prices – CYTOGENETICS DNA PROBE EA is $925
At Aurora Medical Center Sheboygan, we prioritize providing our patients with comprehensive financial information upfront. For Charge Code 10004726, regarding CYTOGENETICS DNA PROBE EA, which is classified under revenue code 311 and associated with CPT code 88271, the designated fee stands at $925. Our aim through the CompareMedCosts program is to furnish you with all the details you need to make informed healthcare decisions, offering clarity and transparency around the costs associated with your care.
-
Drug Safety & Recalls | Drug Safety, Shortages & Recalls | Healthcare Policy & Access | Prescriptions
FDA’s compounded GLP-1 crackdown: What changed after Ozempic, Wegovy, Mounjaro, and Zepbound shortages ended
With semaglutide and tirzepatide shortages resolved, the FDA is tightening scrutiny of mass-marketed compounded GLP-1s. Here is what changed and what patients should ask now.
